arrow
Back
M

Mark E. Cooper

monash university

123H-index
710Paper Count
7.3WCitation Count
Published Papers 348
Publication Date
EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach
err2026-05-29
err0
errOAAI
errMisbah Aziz; Karly C. Sourris; Jairo A. Pinzon-Cortes; Tomasz J. Block; Aozhi Dai; Scott Maxwell; Jun Okabe; Anna C. Calkin; Mark E. Cooper; Karin A. M. Jandeleit-Dahm; Abdul Waheed Khan
errShare
errSave
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
err2025-11-06
err0
PREAI
errMarcel H A Muskiet; Massimo Nardone; Patrick C N Rensen; David Z I Cherney; Mark E Cooper
errShare
errSave
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes
err2025-11-01
err0
errOAAI
errReutens, Anne T.; Lekamlage, Dulari Hakamuwa; Salim, Agus; Shaw, Jonathan E.; Esler, Murray D.; Cooper, Mark E.; Kaye, David M.
errShare
errSave
Lipoxin A4 improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
err2024-11-20
err1
errOAAI
errFu, Ting; Mohan, Muthukumar; Bose, Madhura; Brennan, Eoin P.; Kiriazis, Helen; Deo, Minh; Nowell, Cameron J.; Godson, Catherine; Cooper, Mark E.; Zhao, Peishen; Kemp-Harper, Barbara K.; Woodman, Owen L.; Ritchie, Rebecca H.; Kantharidis, Phillip; Qin, Cheng Xue
errShare
errSave
Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation
err2024-10-01
err0
errOAAI
errChipps, Bradley E.; Papi, Alberto; Beasley, Richard; Israel, Elliot; Panettieri Jr, Reynold A.; Albers, Frank C.; Cooper, Mark; Darken, Patrick; Gilbert, Ileen; Trudo, Frank; Weinberg, Mark; Cappelletti, Christy
errShare
errSave
Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement
err2024-09-23
err0
errOAAI
errSchlaich, Markus P.; Tsioufis, Konstantinos; Taddei, Stefano; Ferri, Claudio; Cooper, Mark; Sindone, Andrew; Borghi, Claudio; Parissis, John; Marketou, Maria; Vintila, Ana Maria; Farcas, Anca; Kiuchi, Marcio G.; Chandrappa, Shukrath
errShare
errSave
Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications
err2024-07-01
err2
PREAI
errRasaratnam, Natasha; Salim, Agus; Blackberry, Irene; Cooper, Mark E.; Magliano, Dianna J.; van Wijngaarden, Peter; Varadarajan, Suresh; Sacre, Julian W.; Shaw, Jonathan E.
errShare
errSave
The Role of Activator Protein-1 Complex in Diabetes-Associated Atherosclerosis: Insights From Single-Cell RNA Sequencing
err2024-06-21
err2
errOAAI
errKhan, Abdul Waheed; Aziz, Misbah; Sourris, Karly C.; Lee, Man K. S.; Dai, Aozhi; Watson, Anna M. D.; Maxwell, Scott; Sharma, Arpeeta; Zhou, Ying; Cooper, Mark E.; Calkin, Anna C.; Murphy, Andrew J.; Baratchi, Sara; Jandeleit-Dahm, Karin A. M.
errShare
errSave
Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes
err2024-03-26
err2
errOAAI
errJandeleit-Dahm, Karin A. M.; Kankanamalage, Haritha R.; Dai, Aozhi; Meister, Jaroslawna; Lopez-Trevino, Sara; Cooper, Mark E.; Touyz, Rhian M.; Kennedy, Christopher R. J.; Jha, Jay C.
errShare
errSave
Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial
err2024-03-01
err2
errOAAI
errHadjadj, Samy; Cooper, Mark E.; Steubl, Dominik; Petrini, Michaela; Hantel, Stefan; Mattheus, Michaela; Wanner, Christoph; Thomas, Merlin C.
errShare
errSave
Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials
err2024-02-01
err3
errOAAI
errMarx, Nikolaus; Kolkailah, Ahmed A.; Rosenstock, Julio; Johansen, Odd Erik; Cooper, Mark E.; Alexander, John H.; Toto, Robert D.; Wanner, Christoph; Espeland, Mark A.; Mattheus, Michaela; Schnaidt, Sven; Perkovic, Vlado; Gollop, Nicholas D.; Mcguire, Darren K.
errShare
errSave
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation
err2024-01-01
err25
errOAAI
errSourris, Karly C.; Ding, Yi; Maxwell, Scott S.; Al-sharea, Annas; Kantharidis, Phillip; Mohan, Muthukumar; Rosado, Carlos J.; Penfold, Sally A.; Haase, Claus; Xu, Yangsong; Forbes, Josephine M.; Crawford, Simon; Ramm, Georg; Harcourt, Brooke E.; Jandeleit-Dahm, Karin; Advani, Andrew; Murphy, Andrew J.; Timmermann, Daniel B.; Karihaloo, Anil; Knudsen, Lotte Bjerre; El-Osta, Assam; Drucker, Daniel J.; Cooper, Mark E.; Coughlan, Melinda T.
errShare
errSave
ALBUTEROL-BUDESONIDE VS ALBUTEROL ALONE USED AS NEEDED IN PARTICIPANTS WITH MILD ASTHMA: DESIGN OF THE BATURA DECENTRALIZED PHASE 3B STUDY
errCHEST
IF8.6
err2023-10-01
err0
PREAI
errLaforce, Craig; Albers, Frank C.; Cappelletti, Christy; Cooper, Mark; Danilewicz, Anna; Dunsire, Lynn; Rees, Robert
errShare
errSave
Circulating epigenomic biomarkers correspond with kidney disease susceptibility in high-risk populations with type 2 diabetes mellitus
err2023-10-01
err1
errOAAI
errKhurana, Ishant; Howard, Natasha J.; Maxwell, Scott; Du Preez, Anelle; Kaipananickal, Harikrishnan; Breen, James; Buckberry, Sam; Okabe, Jun; Al-Hasani, Keith; Nakasatien, Soontaree; Himathongkam, Thep; Cooper, Mark E.; Maple-Brown, Louise; Thewjitcharoen, Yotsapon; Brown, Alex; El-Osta, Assam
errShare
errSave
Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice
err2023-02-01
err7
errOAAI
errHanssen, Nordin M. J.; Tikellis, Chris; Pickering, Raelene J.; Dragoljevic, Dragana; Lee, Man Kit Sam; Block, Tomasz; Scheijen, Jean L. J. M.; Wouters, Kristiaan; Miyata, Toshio; Cooper, Mark E.; Murphy, Andrew J.; Thomas, Merlin C.; Schalkwijk, Casper G.
errShare
errSave